01.
Nature Medicine
2026-06-24
Publisher Correction: Oral small molecule GLP-1 receptor agonist aleniglipron in people with overweight or obesity: a randomized, double-blind, placebo-controlled phase 2b trial
作者:
该条目无摘要（多为勘误、社论或新闻类内容，出版方未提供摘要）